Abstract
Hypoxia, or low oxygen availability, is an important physiological and pathological stimulus for multicellular organisms. Molecularly, hypoxia activates a transcriptional programme directed at restoration of oxygen homoeostasis and cellular survival. In mammalian cells, hypoxia not only activates the HIF (hypoxia-inducible factor) family, but also additional transcription factors such as NF-κB (nuclear factor κB). Here we show that hypoxia activates the IKK–NF-κB [IκB (inhibitor of nuclear factor κB)–NF-κB] pathway and the immune response in Drosophila melanogaster. We show that NF-κB activation is required for organism survival in hypoxia. Finally, we identify a role for the tumour suppressor Cyld, as a negative regulator of NF-κB in response to hypoxia in Drosophila. The results indicate that hypoxia activation of the IKK–NF-κB pathway and the immune response is an important and evolutionary conserved response.
Keywords: Cyld, Drosophila, IKK, NF-κB, hypoxia, immune response
Abbreviations: FIH, factor inhibiting HIF (hypoxia-inducible factor); IAP, inhibitor of apoptosis; IKK, IκB (inhibitor of nuclear factor κB) kinase; IMD, immuno deficient; NF-κB, nuclear factor κB; PHD, prolyhydroxylase; QPCR, quantitative PCR; qRT–PCR, quantitative real-time PCR; siRNA, small interfering RNA; TAK, TGF (transforming growth factor)-β-activated kinase; TNF, tumour necrosis factor; TRAF, TNF receptor-associated factor; VHL, von Hippel Lindau
Short abstract
Here we demonstrate that low oxygen activates the transcription factor, NF-κB and the immune response in Drosophila. We show that deregulation of the NF-κB response following low oxygen, results in decreased survival of these animals.
INTRODUCTION
Hypoxia is an important stimulus involved in both physiological and pathological processes [1]. Appropriate response to hypoxia, is required for correct embryo development in mammalian systems (reviewed in [2]), but not for other multicellular organisms such as Caenorhabditis elegans [3] and Drosophila [4]. However, all of these organisms require the component of the hypoxia response to survive under low oxygen conditions [2–4]. In pathological conditions, such as cancer, hypoxia contributes to the pathology as well as treatment resistance of the disease [5].
At the molecular level, cells respond to hypoxia via the action of a family of transcription factors known as HIFs (hypoxia-inducible factors). HIFs are heterodimers composed of an oxygen-controlled subunit HIF-α, and an oxygen-insensitive partner called HIF-1β [also known as ARNT (aryl hydrocarbon receptor nuclear translocator)] [6]. In mammalians, three isoforms for HIF-α exist, as well as several splice variants for HIF-1β [6]. In organisms, such as the fruit fly, D. melanogaster, only one HIF-α exists, called Sima, whereas its binding partner Tango is the Drosophila homologue of HIF-1β [4,7].
Oxygen regulation of this transcription factor family is conferred by a family of dioxygenases, called PHDs (prolyl hydroxylases) and FIH (factor-inhibiting HIF) [8]. PHD-mediated hydroxylation of HIF-α subunits creates a high affinity-binding site for the tumour suppressor VHL (von Hippel Lindau) protein, which is part of an ubiquitin E3–ligase complex. VHL-dependent ubiquitination of HIF-α results in rapid proteasomal degradation of HIF-α subunits. FIH-dependent hydroxylation, on the other hand, prevents binding of co-activators to the HIF complex, and hence reduces HIF transcriptional activity [9]. The mechanism of oxygen-dependent degradation of HIF-α is also conserved in Drosophila, albeit more simplified, with only one PHD being present (Fatiga) and no FIH homologue being thus far identified [10].
Apart from activation of the HIF system, hypoxia also activates a variety of other transcription factors in mammalian cells and organisms. One important transcription factor activated by hypoxia are members of the NF-κB (nuclear factor κB) family. NF-κB is well known for its role in mediating innate immunity and controlling a variety of survival pathways in the cell [11]. In mammalian systems, NF-κB is composed of five genes, encoding RelA/p65, RelB, cRel, p100/p52 and p105/p50. NF-κB targets are extensive and include genes from many different pathways such as proliferation, apoptosis, inflammation, migration and cell cycle [12].
Given NF-κB's importance, its activation is under precise control and it is very intricate, with numerous feedback mechanisms in place. The best understood activation pathway for NF-κB is following the exposure to the pro-inflammatory cytokine TNF-α (tumour necrosis factor-α). Upon ligand binding to the receptor, adaptor molecules, kinases and ubiquitin ligases are recruited leading to the activation of the TAK [TGF (transforming growth factor)-β-activated kinase]–TAB (TAK-associated binding protein) complex [13]. TAK is essential for the activation of the IKK [IκB (inhibitor of nuclear factor κB) kinase) complex, which in mammalian cells is composed by IKKα, IKKβ and IKKγ [14]. IKK activation leads to phosphorylation of the IκB (inhibitor of κB) proteins, which are instrumental in sequestering NF-κB dimers in the cytoplasm. Upon phosphorylation, IκB proteins are ubiquitinated and degraded by the proteasome, thus releasing NF-κB to translocate to the nucleus, where it binds κB-sites in the promoters and enhancers of its target genes [15].
Many negative feedback points exist in the NF-κB pathway [16]. These are designed to optimal control of the activity of this transcription factor. Interestingly, many of these negative regulators are mutated in human disease [12]. These include IκBs, A20 and Cyld two deubiquitinating enzymes [17]. Cyld is a known tumour suppressor [18] and it is thought to act at the level of adaptor molecules such as TRAFs (TNF receptor-associated factor) and the IKK complex itself, namely on IKKγ ubiquitination [18].
NF-κB's function in Drosophila has been extensively studied and it has been shown to be essential for innate immune responses in this organism. In Drosophila, NF-κB is composed of three members: Dorsal, Dif and Relish. The activation pathway has also been well characterized and it is well conserved in these animals. Homologues for IKK (Ird5 and Kenny) and TAK exist, and these have been shown to be required for activation of NF-κB/Relish following infection [19]. In addition, negative regulators such as IκB (cactus) and Cyld also are present in this organism [19].
Activation of the NF-κB pathway in Drosophila can occur via the Toll or the IMD (immuno deficient) pathways depending, for the most part, on the type of pathogen [19]. While the activation of the Toll pathway leads to cactus degradation and release of Dorsal and Dif, activation of the IMD pathway, requires dTAK1, dIKKβ (Ird5) and culminates in the processing and nuclear accumulation of active Relish [19]. Dorsal, Dif and Relish induce the expression of a variety of anti-immune peptides and proteins that help defend the organism against infection [19].
In this study, we investigated whether hypoxia activates IKK–NF-κB in Drosophila as it occurs in mammalian cells. We show that hypoxia activates NF-κB in an IKK-dependent manner, and that hypoxia-triggered NF-κB-dependent gene expression is induced both in larvae and adult flies. We find that Cyld acts as a negative regulator of this pathway in response to hypoxia. Finally, we show that precise control of the NF-κB response in flies is required for survival in hypoxia in this model organism.
EXPERIMENTAL
Cells
Human cervix carcinoma HeLa, and human osteosarcoma U2OS cell lines were obtained from the A.T.C.C. All cells were maintained at 5% (v/v) CO2 in DMEM (Dulbecco's modified Eagle's medium) (Lonza) supplemented with 10% (v/v) FBS (fetal bovine serum) (Invitrogen), 1% penicillin–streptomycin (Lonza) and 1% L-glutamine (Lonza).
Treatments
Hypoxia treatments were performed in an InVIVO 300 hypoxia workstation (Ruskin). All extracts were performed inside the workstation to avoid re-oxygenation.
Antibodies
Antibodies against HIF-1α were obtained from BD Biosciences; p-RelA (536 and 468), A20, IKKβ and β-actin were from Cell Signalling; RelA from Santa Cruz Biotechnology; IAP1 (inhibitor of apoptosis 1) from R&D systems. ECL (enhanced chemiluminescence, Pierce) was used for detection.
Drosophila strains, protein and mRNA extracts preparation
Fly culture and husbandry were performed according to standard protocols. Homozygous flies carrying Ird51 mutation [20] were used as an IKK loss-of-function model, and CYLDf00814 [21] loss-of-function model. CYLD loss-of-function flies were generated by Exelixis and made available to the fly community via the Bloomington Stock Centre. sima07607 [22] flies were used as an HIF-1α loss-of-function model. White1118 flies were used as control. Third-instar larvae or adults were exposed to 5 or 3% O2 prior to RNA extraction. mRNA extracts we prepared from adult heads or whole-larvae body using TRIzol (Invitrogen). Gene expression levels of several transcripts were measured by qRT–PCR (quantitative real-time PCR). The primers used for qRT–PCR are shown in Table 1.
Table 1. Primers were used for qRT–PCR.
Primer name | Forward sequence (5′→3′) | Reverse sequence (5′→3′) |
---|---|---|
Dractin | GCGTTTTGTACAATTCGTCAGCAACC | GCACGCGAAACTGCAGCCAA |
Sima | AGCCCAATCTGCCGCCAACC | TGGAGGCCAGGTGGTGGGAC |
dLdh | CAGTTCGCAACGAACGCGCA | CAGCTCGCCCTGCAGCTTGT |
Diptericin | ACCGCAGTACCCACTCAATC | ACTTTCCAGCTCGGTTCTGA |
Drosocin | CCATCGTTTTCCTGCTGCTTGC | GTCAGGTGATCCTCGATGGCCA |
Drosomycin | GTTCGCCCTCTTCGCTGTCCTGA | CCTCCTCCTTGCACACACGACG |
Relish | GACCCGAAAGCTCGGCGCAAA | TCGCTCACGAGTTGCGAGCAA |
Dorsal | TGTTCAAATCGCGGGCGTCGA | TCGGACACCTTCGAGCTCCAGAA |
Dif | CGGACGTGAAGCGCCGACTTG | CAGCCGCCTGTTTAGAGCGG |
dCYLD | TGCCTTCCAACTCTCGTCTT | AAGGACGCTGATGAAGGAGA |
Attacin A | AGGTTCCTTAACCTCCAATC | CATGACCAGCATTGTTGTAG |
Attacin B | GGGTAATATTTAACCGAAGT | GTGCTAATCTCTGGTCATC |
Mammalian mRNA extract preparation and QPCR (quantitative PCR) analysis
Total RNA from mammalian cells was extracted using peqGOLD total RNA kit (Peqlab), according to the manufacturer's directions. RNA was converted to cDNA using Quantitect Reverse Transcription Kit (Qiagen). For QPCR, Brilliant II SYBR green kit (Stratagene/Agilent), including specific MX3005P 96 well semi-skirted plates, were used to analyse samples on the Mx3005P QPCR platform (Stratagene/Agilent). Actin was used as a normalizing gene in all experiments. The Primers used for RT–QPCR are shown in Table 2.
Table 2. Primers were used for QPCR.
Primer name | Forward sequence (5′→3′) | Reverse sequence (5′→3′) |
---|---|---|
Actin | CTGGGAGTGGGTGGAGGC | TCAACTGGTCTCAAGTCAGTG |
XIAP (X-linked inhibitor of apoptosis) | CTGTTAAAAGTCATCTTCTCTTGAAA | GACCCTCCCCTTGGACC |
A20 | ACAGCTTTCCGCATATTGCT | TTGACCAGGACTTGGGACTT |
IAP1 | AACTCTTGGCCTTTCATTCG | TGTTGTGATGGTGGCTTGAG |
siRNA (small interfering RNA), whole-cell protein lysates and Western blotting
siRNA transfections, whole-cell protein lysates and Western blotting were performed essentially as described previously [23].
RESULTS
IKK and NF-κB are activated following hypoxia in cancer cells
We have previously shown that hypoxia can lead to activation of the NF-κB pathway, and modulation of NF-κB transcriptional activity in mammalian cells [24,25]. In our studies, we had identified IL-8 (interleukin-8), NF-κB2, and IAP2, as three genes that were induced in hypoxia in a NF-κB-dependent manner [24]. To further understand the significance of NF-κB regulation in hypoxia, we analysed additional NF-κB targets in response to hypoxia. When U2OS and HeLa cells were exposed to 1% O2 we could detect an increase in the levels of A20 and IAP1 proteins following 2 and 4 h exposure to 1% O2 (Figure 1A). However, this increase was no longer evident following 24 h of hypoxia. The increase in these genes was also evident at the transcriptional level, as QPCR analysis demonstrated an increase in the mRNA of these genes following exposure to hypoxia (Figure 1B).
One mechanism by which NF-κB can be modulated is via post-translational modifications, most prevalently phosphorylation [12]. RelA can be phosphorylated by IKK at several sites, including Ser536 and Ser468 [15]. Since we had previously shown that hypoxia activates IKK, we analysed if RelA was phosphorylated at these sites in hypoxia using phospho-specific antibodies (Figure 1C). Exposure of U2OS and HeLa cells to short times of hypoxia lead to increased phosphorylation of both Ser536 and Ser468 residues in RelA, without any changes to the total levels of the protein. Importantly, phosphorylation of Ser536 of RelA following hypoxia was significantly reduced in the absence of IKKβ (Figure 1D). These results further validate the activation of IKK under hypoxia.
Hypoxia activates NF-κB in Drosophila
Given our results in the tissue culture cell model, we wanted to validate our results in the context of a whole organism. To this end, we analysed Drosophila melanogaster, as a model organism where NF-κB activation and function has been well studied [19]. In larvae, hypoxia induced a time-dependent activation of Sima (HIF-1α homologue) and its target Ldh (Figure 2A). Interestingly, hypoxia also led to the induction of the NF-κB subunits dorsal, relish and dif (Figure 2B). To rule out the development-specific responses, we also analysed adult animals. Following hypoxia exposure, sima was induced at the mRNA levels as previously seen in larvae, and, importantly, hypoxia induced the expression of Sima target gene Ldh in adult animals (Figure 2C). As observed in the larvae stage, exposure of Drosophila adults to hypoxia also resulted in the induction of mRNA expression of the NF-κB subunits dorsal, relish and dif (Figure 2D). Taken together these results demonstrate that hypoxia induced mRNA expression of NF-κB independent of the developmental stage.
To determine if elevated NF-κB subunits could result in the induction of NF-κB target genes, we next analysed a panel of known NF-κB-dependent genes in Drosophila. While we could observe an increase in the NF-κB target gene drosomycin in larvae exposed to hypoxia (Figure 3A), we conducted most of our analysis in adult flies, in order to rule out any developmental effects. Hypoxia treatment of adult animals resulted in the induction of all NF-κB-dependent targets analysed, including drosomycin, drosocin, attacin A, diptericin and cyld (Figure 3B). These results demonstrate that hypoxia activates NF-κB and the immune peptide response in Drosophila.
Hypoxia activated NF-κB in Drosophila is Ird5/IKK dependent
Our mammalian studies had demonstrated that hypoxia activates NF-κB in an IKK-dependent manner [24,25]. To determine whether this is also conserved in the Drosophila model, we repeated our analysis in the presence or absence of Ird5 function, the IKK homologue in the fly [19,26]. In the absence of Ird5 function, hypoxia exposure did not result in increased mRNA of both dorsal and relish (Figure 4A). Importantly, the levels of NF-κB-dependent targets were no longer induced by hypoxia, in the absence of a functional Ird5 (Figure 4B). These results indicate that in Drosophila, such as in mammalian systems, hypoxia activates NF-κB in an IKK-dependent manner.
Hypoxia induced NF-κB gene expression in Drosophila is controlled by Cyld
An interesting observation from our analysis of hypoxia induced NF-κB in Drosophila, was the induction of Cyld. Cyld is a tumour suppressor gene and a known negative regulator of NF-κB [18]. We used Cyld loss-of-function Drosophila strains to investigate its role in the NF-κB response to hypoxia. Although the NF-κB subunit relish was unaffected by the presence or absence of cyld, dorsal induction following hypoxia exposure was reduced, indicating that Cyld is required for the up-regulation of this gene in hypoxia (Figure 5A). Interestingly, most of the NF-κB targets we have analysed, were all significantly up-regulated in hypoxia, when the Cyld function was impaired (Figure 5B). These results suggest, that Cyld controls NF-κB activation in hypoxia much like it does in response to infection [27] in this model organism.
Controlled NF-κB activity is required for survival in response to hypoxia
All of our results so far, have implicated IKK and NF-κB in the response to hypoxia in Drosophila. To determine the biological consequences of this requirement, we performed viability measurements using the different Drosophila loss-of-function strains in response to hypoxia (Figure 6). We exposed adult animals to 1% O2 and measured survival in an acute response. As a control, we used a loss of function strain for the HIF-α homologue in Drosophila, Sima [22]. Following 24 h of exposure to 1% O2, sima deficient animals had a significant reduction in survival (Figure 6A). Interestingly, when NF-κB activity is either too low (Ird5) or too high (Cyld), survival is markedly reduced in hypoxia, suggesting that precise control of NF-κB is required for a proper response to hypoxia. We repeated this analysis under milder hypoxia conditions, 3% O2. Under these conditions, the survival is much more prolonged and wild-type animals survive relatively well for several days (Figure 6B). However, Ird5 loss-of-function animals succumb quite rapidly to hypoxia exposure, even under these milder conditions, where sima mutant flies survive to about 75% following 10 days in hypoxia (Figure 6B). Interestingly, Cyld loss-of-function animals also survive less than both wild-type and sima loss-of-function strains indicating that precise control of NF-κB and the immune response in hypoxia, is required for survival of these organisms.
DISCUSSION
In this report, we have investigated how hypoxia impacts on NF-κB in D. melanogaster. We have found that hypoxia activates NF-κB subunits, transcriptional activity and the immune response in the context of a larvae or adult fly. In addition, we demonstrate the requirement of the IKK homologue Ird5, for hypoxia-induced NF-κB, and the involvement of the tumour suppressor Cyld, in the negative regulation of this response.
Drosophila has been used extensively to delineate the innate immune response to bacteria, virus and fungal infection [19,28]. In the fly, innate immune responses can be activated via the Toll or IMD pathways [19,28]. These culminate in the release of an active NF-κB transcription factor, which in Drosophila comprises Dorsal, Dif and Relish [19,28]. Like in mammalian systems, the immune response also requires the activity of the TAK1 homologue [29]. In addition, the negative regulator, tumour suppressor and deubiquitinase Cyld, has also been associated with the control of the immune response in Drosophila [21].
In mammalian systems, hypoxia activates additional transcription factors [30,31], including NF-κB. Our own work, has investigated the mechanism behind NF-κB activation in mammalian cells [24,25]. We have identified the requirement of TAK1 and IKK for hypoxia induced NF-κB in mammalian cells [24,25]. The findings of the present study, demonstrate the crucial importance of Ird5 and NF-κB for the activation of the immune response and importantly survival in hypoxia. This also demonstrates that hypoxia-induced NF-κB is conserved from humans to fruit flies, as NF-κB has been previously shown to be required for survival of mammalian immune cells in hypoxia [32].
Transcriptional analysis of hypoxia-induced responses had previously identified immune genes as being overrepresented in the datasets analysed [33]. As such, our analysis is in agreement with these generic transcriptomic analyses. However, it is not clear why low oxygen would activate the immune response. It is likely that in conditions of infection, low oxygen regions are present and this would increase the immune response, as hypoxia and inflammation are often associated with each other [34]. This could represent an adaptation response of the immune system.
Our results also identify Cyld as a negative regulator of NF-κB activation in hypoxia. Cyld is a tumour suppressor, with roles controlling cell death, cell cycle and immune responses [18]. In mammalian systems, Cyld is a NF-κB target [35] and represses NF-κB in a negative feedback mechanism by its action on IKKγ and adaptor molecules such as TRAF2 and TRAF6 [18]. Thus far, Cyld role in the mammalian response to hypoxia has not been investigated in detail. One study demonstrated that Cyld is targeted for degradation by HPV (human papillomavirus) E6 virus, to prolong NF-κB activation following hypoxia [36]. In Drosophila, Cyld has been previously shown to interact with the IKKγ homologue (Kenny) and restrict NF-κB's activity both in basal and following bacterial infection, via the IMD pathway [27]. Our results are in agreement with this finding, as hypoxia activates mainly the IMD pathway in Drosophila. Our results thus identify Cyld as a component of the hypoxia response in Drosophila.
In mammalian systems, hypoxia has been shown to induce calcium release and subsequent activation of the TAK1 kinase complex [24]. Whether this also happens in Drosophila is not known, and requires further work. In addition, some studies have indicated that PHDs and FIH could control NF-κB activation [37–40]. However, the exact mechanism is still under debate, while some studies suggest a requirement for hydroxylase activity, others suggest that this effect is hydroxylase independent. In Drosophila, there is a single PHD gene, called Fatiga [22], while no FIH isoform has been identified. Unfortunately, the loss-of-function strain for fatiga is embryonic lethal [22] and hence the role of this enzyme in hypoxia induced NF-κB cannot be easily tested. In addition, the putative PHD-dependent hydroxylation motif is not present in Ird5/dIKK, suggesting at least that this is not through this motif that Fatiga could interfere with IKK function in the fly. However, we cannot rule out this possibility entirely thus far.
Unlike the majority of the mammalian cell system analysed, in Drosophila hypoxia activates the transcription of HIF isoforms Sima [23,41] and Tango [23]. Our previous work has indicated that in adult flies this requires the NF-κB subunit Dorsal [23]. Here we also demonstrate the requirement of the Ird5 kinase. As such, it is likely that Sima is regulated by a heterodimer Dorsal/Relish. In mammals, HIF-1α and HIF-1β can be directly regulated at their promoters by NF-κB heterodimers such as RelA/p50 [23,42–44], suggesting an extensive degree of conservation in this regulatory mechanism.
Overall, our study highlights how Drosophila would be a good genetic model to investigate hypoxia and inflammation. In the future, it would be interesting to determine tissue-specific responses and take advantage of the genetic tools available to further dissect the connection between these two conditions, so often present in human pathologies.
ACKNOWLEDGEMENT
We would like to thank members of the S.R. and H.A.M. laboratories for helpful discussions.
AUTHOR CONTRIBUTION
Daniel Bandarra designed, performed and analysed the experiments. John Biddlestone and Sharon Mudie performed experiments. H. Arno Muller designed and analysed the experiments, and helped to write the paper. Sonia Rocha designed, performed and analysed the experiments, and wrote the paper.
FUNDING
D.B. holds a PhD studentship from the Portuguese Science Foundation and Graduate Programme in Areas of Basic and Applied Biology (GABBA), J.B. is a CR-UK clinical fellow, H.A.M. is supported by the Medical Research Council (MRC) [grant numbers MR/K018531/1, G0901020]. The S.R. laboratory is funded by a CR-UK Senior Research Fellowship [grant number C99667/A12918]. This work was supported by a Wellcome Trust Strategic Award [grant numebr 097945/B/11/Z].
References
- 1.Ratcliffe P. J. Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer. J. Physiol. 2013;591:2027–2042. doi: 10.1113/jphysiol.2013.251470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Moniz S., Biddlestone J., Rocha S. Grow(2): The HIF system, energy homeostasis and the cell cycle. Histol. Histopathol. 2014;29:589–600. doi: 10.14670/HH-29.10.589. [DOI] [PubMed] [Google Scholar]
- 3.Jiang H., Guo R., Powell-Coffman J. A. The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia. Proc. Natl. Acad. Sci. U. S. A. 2001;98:7916–7921. doi: 10.1073/pnas.141234698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lavista-Llanos S., Centanin L., Irisarri M., Russo D. M., Gleadle J. M., Bocca S. N., Muzzopappa M., Ratcliffe P. J., Wappner P. Control of the hypoxic response in Drosophila melanogaster by the basic helix-loop-helix PAS protein similar. Mol. Cell. Biol. 2002;22:6842–6853. doi: 10.1128/MCB.22.19.6842-6853.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Semenza G. L. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J. Clin. Invest. 2013;123:3664–3671. doi: 10.1172/JCI67230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rocha S. Gene regulation under low oxygen: holding your breath for transcription. Trends Biochem. Sci. 2007;32:389–397. doi: 10.1016/j.tibs.2007.06.005. [DOI] [PubMed] [Google Scholar]
- 7.Sonnenfeld M., Ward M., Nystrom G., Mosher J., Stahl S., Crews S. The Drosophila tango gene encodes a bHLH-PAS protein that is orthologous to mammalian ARNT and controls CNS midline and tracheal development. Development. 1997;124:4571–4582. doi: 10.1242/dev.124.22.4571. [DOI] [PubMed] [Google Scholar]
- 8.Fandrey J., Gorr T. A., Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc. Res. 2006;71:642–651. doi: 10.1016/j.cardiores.2006.05.005. [DOI] [PubMed] [Google Scholar]
- 9.Lando D., Peet D. J., Gorman J. J., Whelan D. A., Whitelaw M. L., Bruick R. K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002;16:1466–1471. doi: 10.1101/gad.991402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Romero N. M., Dekanty A., Wappner P. Cellular and developmental adaptations to hypoxia: a Drosophila perspective. Methods Enzymol. 2007;435:123–144. doi: 10.1016/S0076-6879(07)35007-6. [DOI] [PubMed] [Google Scholar]
- 11.Tornatore L., Thotakura A. K., Bennett J., Moretti M., Franzoso G. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol. 2012;22:557–566. doi: 10.1016/j.tcb.2012.08.001. [DOI] [PubMed] [Google Scholar]
- 12.Perkins N. D. The diverse and complex roles of NF-kappa B subunits in cancer. Nat. Rev. Cancer. 2012;12:121–132. doi: 10.1038/nrc3204. [DOI] [PubMed] [Google Scholar]
- 13.Silke J. The regulation of TNF signalling: what a tangled web we weave. Curr. Opin. Immunol. 2011;23:620–626. doi: 10.1016/j.coi.2011.08.002. [DOI] [PubMed] [Google Scholar]
- 14.Liu F., Xia Y., Parker A. S., Verma I. M. IKK biology. Immunol. Rev. 2012;246:239–253. doi: 10.1111/j.1600-065X.2012.01107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Perkins N. D. Integrating cell-signalling pathways with NF-kappa B and IKK function. Nat. Rev. Mol. Cell Biol. 2007;8:49–62. doi: 10.1038/nrm2083. [DOI] [PubMed] [Google Scholar]
- 16.Ruland J. Return to homeostasis: down-regulation of NF-kappa B responses. Nat. Immunol. 2011;12:709–714. doi: 10.1038/ni.2055. [DOI] [PubMed] [Google Scholar]
- 17.Harhaj E. W., Dixit V. M. Regulation of NF-kappa B by deubiquitinases. Immunol. Rev. 2012;246:107–124. doi: 10.1111/j.1600-065X.2012.01100.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Massoumi R. Ubiquitin chain cleavage: CYLD at work. Trends Biochem. Sci. 2010;35:392–399. doi: 10.1016/j.tibs.2010.02.007. [DOI] [PubMed] [Google Scholar]
- 19.Hetru C., Hoffmann J. A. NF-kappaB in the immune response of Drosophila. Cold Spring Harb. Perspect. Biol. 2009;1:a000232. doi: 10.1101/cshperspect.a000232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lu Y., Wu L. P., Anderson K. V. The antibacterial arm of the Drosophila innate immune response requires an IkappaB kinase. Genes Dev. 2001;15:104–110. doi: 10.1101/gad.856901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Tsichritzis T., Gaentzsch P. C., Kosmidis S., Brown A. E., Skoulakis E. M., Ligoxygakis P., Mosialos G. A Drosophila ortholog of the human cylindromatosis tumor suppressor gene regulates triglyceride content and antibacterial defense. Development. 2007;134:2605–2614. doi: 10.1242/dev.02859. [DOI] [PubMed] [Google Scholar]
- 22.Centanin L., Ratcliffe P. J., Wappner P. Reversion of lethality and growth defects in Fatiga oxygen-sensor mutant flies by loss of hypoxia-inducible factor-alpha/Sima. EMBO Rep. 2005;6:1070–1075. doi: 10.1038/sj.embor.7400528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.van Uden P., Kenneth N. S., Webster R., Muller H. A., Mudie S., Rocha S. Evolutionary conserved regulation of HIF-1beta by NF-kappa B. PLoS Genet. 2011;7:e1001285. doi: 10.1371/journal.pgen.1001285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Culver C., Sundqvist A., Mudie S., Melvin A., Xirodimas D., Rocha S. Mechanism of hypoxia-induced NF-kappaB. Mol. Cell. Biol. 2010;30:4901–4921. doi: 10.1128/MCB.00409-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Melvin A., Mudie S., Rocha S. Further insights into the mechanism of hypoxia-induced NF-kappa B. Cell Cycle. 2011;10:879–882. doi: 10.4161/cc.10.6.14910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Silverman N., Zhou R., Stoven S., Pandey N., Hultmark D., Maniatis T. A Drosophila Ikappa B kinase complex required for Relish cleavage and antibacterial immunity. Genes Dev. 2000;14:2461–2471. doi: 10.1101/gad.817800. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Glittenberg M., Ligoxygakis P. CYLD: a multifunctional deubiquitinase. Fly (Austin) 2007;1:330–332. doi: 10.4161/fly.5399. [DOI] [PubMed] [Google Scholar]
- 28.Kounatidis I., Ligoxygakis P. Drosophila as a model system to unravel the layers of innate immunity to infection. Open Biol. 2012;2:120075. doi: 10.1098/rsob.120075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Silverman N., Zhou R., Erlich R. L., Hunter M., Bernstein E., Schneider D., Maniatis T. Immune activation of NF-kappa B and JNK requires Drosophila TAK1. J. Biol. Chem. 2003;278:48928–48934. doi: 10.1074/jbc.M304802200. [DOI] [PubMed] [Google Scholar]
- 30.Kenneth N. S., Rocha S. Regulation of gene expression by hypoxia. Biochem. J. 2008;414:19–29. doi: 10.1042/BJ20081055. [DOI] [PubMed] [Google Scholar]
- 31.Cummins E. P., Taylor C. T. Hypoxia-responsive transcription factors. Pflugers Arch. 2005;450:363–371. doi: 10.1007/s00424-005-1413-7. [DOI] [PubMed] [Google Scholar]
- 32.Walmsley S. R., Print C., Farahi N., Peyssonnaux C., Johnson R. S., Cramer T., Sobolewski A., Condliffe A. M., Cowburn A. S., Johnson N., Chilvers E. R. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappa B activity. J. Exp. Med. 2005;201:105–115. doi: 10.1084/jem.20040624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Azad P., Zhou D., Russo E., Haddad G. G. Distinct mechanisms underlying tolerance to intermittent and constant hypoxia in Drosophila melanogaster. PLoS ONE. 2009;4:e5371. doi: 10.1371/journal.pone.0005371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Bartels K., Grenz A., Eltzschig H. K. Hypoxia and inflammation are two sides of the same coin. Proc. Natl. Acad. Sci. U. S. A. 2013;110:18351–18352. doi: 10.1073/pnas.1318345110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Jono H., Lim J. H., Chen L. F., Xu H., Trompouki E., Pan Z. K., Mosialos G., Li J. D. NF-kappa B is essential for induction of CYLD, the negative regulator of NF-kappa B: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem. 2004;279:36171–36174. doi: 10.1074/jbc.M406638200. [DOI] [PubMed] [Google Scholar]
- 36.An J., Mo D., Liu H., Veena M. S., Srivatsan E. S., Massoumi R., Rettig M. B. Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappa B activation. Cancer Cell. 2008;14:394–407. doi: 10.1016/j.ccr.2008.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Cummins E. P., Berra E., Comerford K. M., Ginouves A., Fitzgerald K. T., Seeballuck F., Godson C., Nielsen J. E., Moynagh P., Pouyssegur J., Taylor C. T. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NF-kappa B activity. Proc. Natl. Acad. Sci. U. S. A. 2006;103:18154–18159. doi: 10.1073/pnas.0602235103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Xue J., Li X., Jiao S., Wei Y., Wu G., Fang J. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology. 2010;138:606–615. doi: 10.1053/j.gastro.2009.09.049. [DOI] [PubMed] [Google Scholar]
- 39.Fu J., Taubman M. B. EGLN3 inhibition of NF-kappa B is mediated by prolyl hydroxylase-independent inhibition of IkappaB kinase gamma ubiquitination. Mol. Cell. Biol. 2013;33:3050–3061. doi: 10.1128/MCB.00273-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Scholz C. C., Taylor C. T. Hydroxylase-dependent regulation of the NF-kappa B pathway. Biol. Chem. 2013;394:479–493. doi: 10.1515/hsz-2012-0338. [DOI] [PubMed] [Google Scholar]
- 41.Dekanty A., Romero N. M., Bertolin A. P., Thomas M. G., Leishman C. C., Perez-Perri J. I., Boccaccio G. L., Wappner P. Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxia. PLoS Genet. 2010;6:e1000994. doi: 10.1371/journal.pgen.1000994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Bonello S., Zahringer C., BelAiba R. S., Djordjevic T., Hess J., Michiels C., Kietzmann T., Gorlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NF-kappaB site. Arterioscler. Thromb. Vasc. Biol. 2007;27:755–761. doi: 10.1161/01.ATV.0000258979.92828.bc. [DOI] [PubMed] [Google Scholar]
- 43.Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A. S., Nizet V., Johnson R. S., Haddad G. G., Karin M. NF-kappa B links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008;453:807–811. doi: 10.1038/nature06905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.van Uden P., Kenneth N. S., Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappa B. Biochem. J. 2008;412:477–484. doi: 10.1042/BJ20080476. [DOI] [PMC free article] [PubMed] [Google Scholar]